Repare Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy RPTX

*Your capital is at risk

$2.65

+0 (+0%)

At Close: Apr 24, 2026

Currently predicting for Thu, 6 Aug 2026

RPTX Live board

Community Bull/Bear

Target Next close

Join the RPTX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

RPTX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For RPTX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

RPTX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT REPARE THERAPEUTICS INC.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an ora...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FCX $62.63	7.46%	Jul 31
MC $67.08	2.40%	Jul 31
ARW $212.85	6.96%	Jul 30
BIIB $202.19	3.10%	Jul 24
F FERG $230.67	10.77%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by